全文获取类型
收费全文 | 238533篇 |
免费 | 4717篇 |
国内免费 | 688篇 |
专业分类
耳鼻咽喉 | 2290篇 |
儿科学 | 7378篇 |
妇产科学 | 3946篇 |
基础医学 | 27635篇 |
口腔科学 | 2992篇 |
临床医学 | 17925篇 |
内科学 | 42628篇 |
皮肤病学 | 2989篇 |
神经病学 | 20952篇 |
特种医学 | 12468篇 |
外科学 | 36816篇 |
综合类 | 2549篇 |
现状与发展 | 2篇 |
一般理论 | 17篇 |
预防医学 | 21085篇 |
眼科学 | 4228篇 |
药学 | 15098篇 |
中国医学 | 1432篇 |
肿瘤学 | 21508篇 |
出版年
2023年 | 487篇 |
2022年 | 1614篇 |
2021年 | 2446篇 |
2020年 | 1192篇 |
2019年 | 1586篇 |
2018年 | 23656篇 |
2017年 | 18677篇 |
2016年 | 21416篇 |
2015年 | 4017篇 |
2014年 | 4472篇 |
2013年 | 4957篇 |
2012年 | 13131篇 |
2011年 | 26399篇 |
2010年 | 21948篇 |
2009年 | 14154篇 |
2008年 | 23213篇 |
2007年 | 25047篇 |
2006年 | 3612篇 |
2005年 | 4898篇 |
2004年 | 5668篇 |
2003年 | 6239篇 |
2002年 | 4097篇 |
2001年 | 1686篇 |
2000年 | 1715篇 |
1999年 | 1098篇 |
1998年 | 586篇 |
1997年 | 482篇 |
1996年 | 320篇 |
1995年 | 296篇 |
1994年 | 262篇 |
1993年 | 205篇 |
1992年 | 381篇 |
1991年 | 410篇 |
1990年 | 411篇 |
1989年 | 347篇 |
1988年 | 306篇 |
1987年 | 297篇 |
1986年 | 208篇 |
1985年 | 202篇 |
1984年 | 146篇 |
1983年 | 135篇 |
1982年 | 80篇 |
1981年 | 62篇 |
1980年 | 81篇 |
1979年 | 87篇 |
1978年 | 79篇 |
1974年 | 80篇 |
1970年 | 68篇 |
1938年 | 62篇 |
1932年 | 63篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
François Béïque Mohamed Ali Scott MacKenzie Mark Hynes 《Journal canadien d'anesthésie》2007,54(2):158-159
73.
74.
Su Jin Park Su Jin Kim Yumie Rhee Ji Hyun Byun Seong Hwan Kim Myoung Hee Kim Eun Jig Lee Sung-Kil Lim 《Journal of bone and mineral research》2007,22(6):889-896
The FIGNL1 gene was proven to be a new subfamily member of ATPases associated with diverse cellular activities (AAA proteins). In this in vitro study, the AAA proteins inhibited osteoblast proliferation and stimulated osteoblast differentiation. We showed that FIGNL1 may play some regulatory role in osteoblastogenesis. INTRODUCTION: The fidgetin-like 1 (FIGNL1) gene encodes a new subfamily member of ATPases associated with diverse cellular activities (AAA proteins). Although the FIGNL1 protein localizes to both the nucleus and cytoplasm, the function of FIGNL1 remains unknown. In a previous study, we identified several genes that mediate the anabolic effects of basic fibroblast growth factor (bFGF) on bone by using microarray data. FIGNL1 was one of the genes that downregulated >2-fold in MC3T3-E1 cells after treatment with bFGF. Therefore, this study was aimed to identify and confirm the function of FIGNL1 on osteoblastogenesis. MATERIALS AND METHODS: We examined the effect of the FIGNL1 gene on proliferation, differentiation, and apoptosis in mouse osteoblast cells (MC3T3-E1 and mouse primary calvarial cells) using flow cytometry, RT-PCR, cell proliferation assay, and cell death assay. MC3T3-E1 cells and mouse calvarial cells were transfected with small interfering RNA (siRNA) directed against the FIGNL1 or nontargeting control siRNA and examined by cell proliferation and cell death assays. Also, FIGNL1 was fused to enhance green fluorescent protein (EGFP), and the EGFP-fused protein was transiently expressed in MC3T3-E1 cells. RESULTS: Reduced expression of FIGNL1 by bFGF and TGF-beta1 treatment was verified by RT-PCR analysis. Overexpression of FIGNL1 reduced the proliferation of MC3T3-E1 and calvarial cells, more than the mock transfected control cells did. In contrast, siFIGNL1 transfection significantly increased the proliferation of osteoblasts, whereas overexpression of FIGNL1 did not seem to alter apoptosis in osteoblasts. Meanwhile, overexpression of FIGNL1 enhanced the mRNA expression of alkaline phosphatase (ALP) and osteocalcin (OCN) in osteoblasts. In contrast, siFIGNL1 decreased the expression of ALP and OCN. A pEGFP-FIGNL1 transfected into MCT3-E1 cells had an initially ubiquitous distribution and rapidly translocated to the nucleus 1 h after bFGF treatment. CONCLUSIONS: From these results, we proposed that FIGNL1, a subfamily member of the AAA family of proteins, might play some regulatory role in osteoblast proliferation and differentiation. Further analyses of FIGNL1 will be needed to better delineate the mechanisms contributing to the inhibition of proliferation and stimulation of osteoblast differentiation. 相似文献
75.
76.
77.
78.
Late-onset and Recurrent Neonatal Group B Streptococcal Disease Associated with Breast-milk Transmission 总被引:2,自引:0,他引:2
Michael Kotiw Gwang W. Zhang Grant Daggard Elizabeth Reiss-Levy John W. Tapsall Andrew Numa 《Pediatric and developmental pathology》2003,6(3):251-256
The purpose of the study was to determine the epidemiological relationships in three unrelated cases of neonatal late-onset Group B streptococcal (GBS) disease and maternal breast-milk infection with GBS. All deliveries were by cesarean section; case 1 was at term, and cases 2 and 3 were at 32- and 33-wk gestation, respectively. Case 1 relates to a mother with clinical mastitis and recurrent GBS infection in a 20-day-old male infant. Following antibiotic therapy and cessation of breast-feeding, the infant recovered without sequelae. Case 2 refers to a mother with clinical mastitis and the occurrence of late-onset GBS disease in 5-wk-old male twins. Despite intervention, one infant died and the second became ill. Following antibiotic therapy and cessation of breast-feeding, the surviving infant recovered without sequelae. Case 3 refers to a mother with sub-clinical mastitis and late-onset GBS infection occurring in a 6-day-old female twin. Following intervention, the infant recovered but suffered a bilateral thalamic infarction resulting in developmental delay and a severe seizure disorder. Following recovery of GBS from an inapparent mastitis and cessation of breast-feeding, the second infant remained well. Blood cultures from all affected infants and maternal breast milk were positive for GBS. Epidemiological relationships between neonatal- and maternal-derived GBS isolates were confirmed by a random amplified polymorphic DNA polymerase chain reaction assay (RAPD-PCR). This study is significant in that it has demonstrated that maternal milk (in cases of either clinical or sub-clinical mastitis) can be a potential source of infection resulting in either late-onset or recurrent neonatal GBS disease. 相似文献
79.
Ona Faye-Petersen 《Pediatric and developmental pathology》2003,6(6):599-600
80.
Seong-Beom Koh Byung-Jo Kim Moon Ho Park Sung-Wook Yu Kun-Woo Park Dae Hie Lee 《Journal of clinical neuroscience》2007,14(11):1073-1077
Cerebral infarction as a complication of tubercular (TB) meningitis is not uncommon, but an adequate comparison of patients with and without stroke has not been carried out. This study was performed to evaluate the clinical characteristics of cerebral infarction secondary to TB meningitis, and to investigate predictive factors for cerebral infarction in patients with TB meningitis. Patients with TB meningitis were recruited over a period of 56 months. They were divided into two groups, those with and those without stroke. Demographic features and clinical, laboratory, and neuroradiological findings were compared between the two groups. We classified strokes into subtypes using neuroimaging findings. Of the 38 patients who were diagnosed with TB meningitis, eight also experienced cerebral infarction. The percentage of cerebrospinal fluid leukocytes that were neutrophils was significantly higher in patients with stroke (68%) than in patients without stroke (31%; p=0.0001). Upon initial CT imaging, meningeal enhancement was found in 11 patients, and of these patients, six experienced stroke. There were no significant differences between the groups with respect to other clinical and laboratory features, including demographic features, time between meningitis onset and treatment initiation, peripheral white blood cell count, and cerebrospinal fluid findings. Five of the eight patients who developed stroke had lacunar infarcts. One of the three patients with territorial nonlacunar infarction died due to herniation. When treating patients with TB meningitis, the possibility of cerebral infarction should be considered when patients develop focal neurological signs, meningeal enhancement on a CT scan, and sustained polymorphic cerebrospinal fluid pleocytosis. 相似文献